and continued growth in Zevalin and Fotolyn are what chop liver? And trial drugs Apiq. and Benlo. would not point to a better PPS in future? Look neither short nor long has made out the PPS is stalled in the $11-12 range over last 4 quarters . Both sides have arguments to make but if this were a trial it would be a hung jury. So don't expect much action either way . The only big action will be NDA submission or buyout .